187 related articles for article (PubMed ID: 8679157)
1. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
Holly A; Sittinger M; Bujia J
Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical detection of c-myc proto-oncogene products in middle ear cholesteatoma].
Holly A; Sittinger M; Bujía J
Laryngorhinootologie; 1995 Jun; 74(6):348-51. PubMed ID: 7662077
[TBL] [Abstract][Full Text] [Related]
3. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of TERT and c-Myc oncogene protein product on cholesteatoma epithelium].
Zhang F; Liu J; Yuan T; Liu Q; Han Z; Wang S; Zhang C; Chen S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):302-4. PubMed ID: 16001896
[TBL] [Abstract][Full Text] [Related]
5. Heat shock proteins in middle ear cholesteatoma.
Shinoda H; Huang CC
Otolaryngol Head Neck Surg; 1996 Jan; 114(1):77-83. PubMed ID: 8570255
[TBL] [Abstract][Full Text] [Related]
6. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
Shinoda H; Huang CC
Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
[TBL] [Abstract][Full Text] [Related]
8. [Expression of calgranulin A and B in middle ear cholesteatoma].
Holly A; Bujía J; Lempart K; Serge M
Laryngorhinootologie; 1995 Jan; 74(1):33-5. PubMed ID: 7888019
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
Bujia J; Sudhoff H; Holly A; Hildmann H; Kastenbauer E
Eur Arch Otorhinolaryngol; 1996; 253(1-2):21-4. PubMed ID: 8932424
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical studies with middle ear mucosal remnants in cholesteatoma].
Sudhoff H; Borkowski G; Bujia J; Hildmann H; Fisseler-Eckhoff A
HNO; 1997 Aug; 45(8):630-5. PubMed ID: 9378670
[TBL] [Abstract][Full Text] [Related]
11. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.
Shinoda H; Huang CC
Eur Arch Otorhinolaryngol; 1995; 252(7):385-90. PubMed ID: 8562031
[TBL] [Abstract][Full Text] [Related]
12. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium.
Kojima H; Miyazaki H; Tanaka Y; Shiwa M; Koga T; Moriyama H
Arch Otolaryngol Head Neck Surg; 1999 Jul; 125(7):738-42. PubMed ID: 10406309
[TBL] [Abstract][Full Text] [Related]
13. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma.
Bujía J; Holly A; Schilling V; Negri B; Pitzke P; Schulz P
Laryngoscope; 1993 Mar; 103(3):326-9. PubMed ID: 7680089
[TBL] [Abstract][Full Text] [Related]
15. Alteration of epidermal differentiation in middle ear cholesteatoma.
Stammberger M; Bujía J; Kastenbauer E
Am J Otol; 1995 Jul; 16(4):527-31. PubMed ID: 8588655
[TBL] [Abstract][Full Text] [Related]
16. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.
Sudhoff H; Bujía J; Fisseler-Eckhoff A; Holly A; Schulz-Flake C; Hildmann H
Laryngoscope; 1995 Nov; 105(11):1227-31. PubMed ID: 7475881
[TBL] [Abstract][Full Text] [Related]
17. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
18. Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1.
Bujía J; Holly A; Antolí-Candela F; Tapia MG; Kastenbauer E
Laryngoscope; 1996 Jul; 106(7):865-8. PubMed ID: 8667984
[TBL] [Abstract][Full Text] [Related]
19. [Expression of 4F2-activation antigen in middle ear cholesteatoma].
Holly A; Bujía J; Sanchez-Madrid F
Laryngorhinootologie; 1993 Jul; 72(7):324-7. PubMed ID: 8369083
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes.
Vennix PP; Kuijpers W; Peters TA; Tonnaer EL; Ramaekers FC
Arch Otolaryngol Head Neck Surg; 1996 Aug; 122(8):825-32. PubMed ID: 8703383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]